// App-Quantinova.ai

: Minimising Transfusion Therapy and Alloimmunisation in Patients with Sickle Cell Disorder in the Era of Hydroxyurea

Researchers

Presenter

  • Louise Smith

Principal Investigators

  • Lucy Stead

  • Russell D Keenan

  • Rekha Thangavelu

Medical Centers

  • Haematology Treatment Centre, Alder Hey Children's Hospital, Liverpool, United Kingdom

  • Haematology Treatment Centre, Alder Hey Children's Hospital, Liverpool, United Kingdom

  • Microbiology, Alder Hey Childrens Hospital, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute chest syndrome

  • Sickle cell anemia

Biomarkers

  • Estrogen receptor alpha

  • Red Blood Cells

Drug/Treatment

  • Hydroxycarbamide

  • Hydroxyurea

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved